0001950047-24-002714.txt : 20240327 0001950047-24-002714.hdr.sgml : 20240327 20240327161405 ACCESSION NUMBER: 0001950047-24-002714 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 24790777 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Mesa Nilda CENTRAL INDEX KEY: 0001756697 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORPORATION STREET 2: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 144 1 primary_doc.xml 144 0001756697 XXXXXXXX LIVE 0001082554 UNITED THERAPEUTICS CORPORATION 000-26301 1000 Spring Street SILVER SPRING MD 20910 (301) 608-9292 NILDA MESA Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

325 77285.00 47058545 03/27/2024 NASDAQ Common 06/29/2020 Restricted Stock Issuer N 233 06/29/2020 Not Applicable Common 07/08/2022 Restricted Stock Issuer N 92 07/08/2022 Not Applicable Y 03/27/2024 /s/ Nilda Mesa